-- 
Berkshire Hathaway, ImmunoGen, United Therapeutics: U.S. Equity Movers

-- B y   J o a n n a   O s s i n g e r
-- 
2011-09-26T20:22:33Z

-- http://www.bloomberg.com/news/2011-09-23/ch-energy-clorox-pfizer-transatlantic-u-s-equity-preview.html
Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses and prices are as of 4 p.m. New York time.  Banks advanced amid speculation that the  European Central
Bank  may restart covered-bond purchases next week and cut
interest rates next month.  Deutsche Bank AG (DB)   jumped 12
percent to $35.15.  Bank of America Corp. (BAC)   increased 4.6
percent to $6.60.  JPMorgan Chase & Co. (JPM)   advanced 7
percent to $31.65.  First Horizon National Corp. (FHN)   rose
7.1 percent to $6.51.  UBS AG (UBSN)   advanced 8 percent to $12.15. The largest
Swiss bank’s Chief Executive Officer  Oswald Gruebel  quit this
weekend, and interim CEO  Sergio Ermotti  said one of his first
priorities was to complete a review of “operational risk
infrastructure.”  American Eagle Outfitters Inc. (AEO)   rose 7.8 percent,
the most since Feb. 10, to $12.04. Chairman Jay Schottenstein
disclosed Sept. 23 that he bought $1 million worth of shares in
the Pittsburgh-based teen-apparel retailer. His purchase signals
that executives are confident in the company’s future, said
Betty Chen, an analyst at San Francisco-based Wedbush
Securities.  Berkshire Hathaway Inc. (BRK/A)  (BRK/B US) advanced the second-most
in the Standard & Poor’s 500 Index, rallying 8.6 percent to
$72.09. The company led by billionaire investor  Warren Buffett 
will repurchase shares for as much as 110 percent of their book
value, saying the stock is undervalued after falling 17 percent
this year.  Boeing Co. (BA)   rose 4.2 percent, the most since Aug.
12, to $62.01. The planemaker hands over the first 787
Dreamliner today to end more than three years of delays for a
plane that the company says will become a benchmark for decades
for technology and passenger amenities.  Clorox Co. (CLX)   declined 4.3 percent to $66.44 for the
fourth-biggest drop in the  S&P 500 .  Carl Icahn , the bleach
maker’s largest investor, withdrew his director slate for the
company after concluding that shareholders wouldn’t support the
move.  Eastman Kodak Co. (EK)   slumped 27 percent to $1.74, the
the biggest decline since January 2009. The cost to protect the
131-year-old camera maker debt from default rose to the highest
level in more than a month after the company drew down $160
million from its revolving bank line.  ImmunoGen Inc. (IMGN)   climbed 6.7 percent, the most
since Aug. 15, to $10.95. The maker of anticancer drugs had its
“buy” rating reiterated by Canaccord Genuity analyst  George Farmer , who said phase 2 trial results for its T-DM1 drug for
metastatic  breast cancer  were “striking” and support “benefit
and commercial potential.”  Odyssey Marine Exploration Inc. (OMEX)   rallied 7.5
percent to $2.86, gaining for a third day. The explorer of
sunken treasure confirmed the discovery of the SS Gairsoppa
shipwreck, which was carrying 7 million total ounces of silver.  Safeway Inc. (SWY)   rose 5.4 percent, the most since
January 2010, to $16.93. Longbow Research raised its
recommendation on the grocer to “neutral” from “sell” with a
price estimate of $17 a share.  United Therapeutics Corp. (UTHR)   fell 5.8 percent to
$38.35, the lowest price since May 2009. Novartis AG (NOVN VX)
announced positive Phase III data for oral, once-daily Gleevec,
which RBC Capital Markets LLC analyst  Michael Yee  said “could
come to market now” as a competitor to the  Silver Spring ,
Maryland-based drugmaker’s Tyvaso treatment.  To contact the reporter on this story:
Joanna Ossinger in New York at 
 jossinger@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at 
 nbaker7@bloomberg.net  